Citigroup Inc Biogen Inc. Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Biogen Inc. stock. As of the latest transaction made, Citigroup Inc holds 223,347 shares of BIIB stock, worth $38.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

223,347

Previous 218,717 2.12%

Holding current value

$38.8 Million

Previous $47.2 Million 9.79%

% of portfolio

0.03%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$190.52 - $236.72 $882,107 - $1.1 Million	4,630 Added 2.12%	223,347 $51.8 Million
Q1 2024 May 10, 2024	SELL	$212.02 - $267.71 $410,470 - $518,286	-1,936 Reduced 0.88%	218,717 $47.2 Million
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $245,961 - $296,073	-1,105 Reduced 0.5%	220,653 $57.1 Million
Q3 2023 Nov 09, 2023	SELL	$253.3 - $285.89 $3.33 Million - $3.76 Million	-13,144 Reduced 5.6%	221,758 $57 Million
Q2 2023 Aug 10, 2023	BUY	$275.25 - $318.06 $1.36 Million - $1.57 Million	4,936 Added 2.15%	234,902 $66.9 Million
Q1 2023 May 11, 2023	BUY	$256.56 - $292.34 $8.5 Million - $9.69 Million	33,140 Added 16.84%	229,966 $63.9 Million
Q4 2022 Feb 09, 2023	SELL	$252.44 - $306.72 $14.7 Million - $17.9 Million	-58,384 Reduced 22.88%	196,826 $54.5 Million
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $13.4 Million - $18.5 Million	68,887 Added 36.97%	255,210 $68.1 Million
Q2 2022 Aug 10, 2022	SELL	$187.54 - $223.02 $3.65 Million - $4.34 Million	-19,455 Reduced 9.45%	186,323 $38 Million
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $34.3 Million - $43.2 Million	-176,956 Reduced 46.23%	205,778 $43.3 Million
Q4 2021 Feb 10, 2022	BUY	$223.92 - $287.77 $25.1 Million - $32.2 Million	112,061 Added 41.4%	382,734 $91.8 Million
Q3 2021 Nov 10, 2021	BUY	$282.99 - $369.05 $76.6 Million - $99.9 Million	270,673 New	270,673 $76.6 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account